查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2022760

雨生红球藻全球市场（按产品、应用和地区划分）：预测（至 2036 年）

Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients; Astaxanthin Bulk Finished Products ); Application (Nutraceuticals, Aquaculture & Animal Feed, Cosmetics, Food & Beverages, Pharmaceuticals), and Geography - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 290 Pages | 商品交期: 5-7个工作天内

价格
简介目录

全球雨生红球藻市场预计将从2026年的1.164亿美元成长至2036年的3.488亿美元，预测期间（2026-2036年）复合年增长率（CAGR）为11.6%。以产量计算，市场规模预计将从2026年的682吨成长至2036年的约2,693吨，复合年增长率为13.0%。市场成长的主要驱动因素包括：营养保健品和膳食补充剂领域对天然虾青素的需求不断增长；天然色素和洁净标示成分的需求不断增长；以及水产养殖和动物营养领域对天然虾青素的日益广泛应用。

雨生红球藻是一种淡水微藻类，是目前已知最丰富的天然虾青素来源，其干生物量中可累积高达3-5%的这种强效酮类胡萝卜素。研究表明，雨生红球藻中的天然虾虾青素的抗氧化能力远远超过维生素C和维生素E等传统抗氧化剂。推动市场成长的关键因素包括消费者对天然类胡萝卜素健康益处的认知不断提高，以及下游产业在全球范围内从合成抗氧化剂转向天然、洁净标示抗氧化剂。儘管高昂的生产成本和复杂的培养过程仍然是挑战，但光生物反应器技术的进步以及在机能性食品和饮料领域应用的不断拓展有望带来巨大的成长机会。

目录

第一章：引言

第二章 分析方法

第三章执行摘要

  • 市场分析：按产品划分
  • 市场分析：按应用领域
  • 市场分析：按地区划分
  • 竞争分析

第四章 市场洞察

  • 市场驱动因素
    • 营养保健品和膳食补充剂对天然虾青素的需求日益增长
    • 消费者对天然食用色素和洁净标示成分的需求日益增长。
    • 扩大天然虾青素在水产养殖和动物营养的应用。
    • 抗衰老和防紫外线特性推动了化妆品应用范围的扩大。
    • 越来越多的研究支持虾青素对健康的益处。
  • 市场限制因素
    • 天然虾青素生产成本高
    • 复杂的培养与萃取过程
  • 市场机会
    • 光生物反应器培养技术的进展
    • 在机能性食品和饮料领域的应用拓展
    • 化妆品和个人保健产品。
  • 市场挑战
    • 水产养殖领域与合成虾虾青素的竞争
    • 供应链限制和生产扩充性
  • 市场趋势
    • 封闭式光生物反应器生产系统的扩展
    • 微胶囊化与稳定化技术的发展
    • 运动营养领域对天然虾青素的需求日益增长。
  • 波特五力分析
  • 价值链分析
    • 菌株开发及接种物製备
    • 水产养殖（开放式池塘、封闭式光生物反应器系统）
    • 收穫和生物质加工
    • 虾青素的萃取与纯化
    • 配方和包装
    • 分销和最终用途

第五章：雨生红球菌市场评估：依产品分类

  • 虾青素素原料
    • 虾青素树脂
    • 珠
    • 生物质粉末
    • 水溶性粉末
  • 虾青素製剂
    • 胶囊/软胶囊
    • 药片
    • 液体

第六章：雨生红球藻市场评估：依应用领域

  • 营养保健品 - 膳食补充剂
  • 水产养殖/动物饲料
  • 化妆品和个人护理
  • 食品/饮料
  • 製药

第七章：血球菌市场分析：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 丹麦
    • 瑞典
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 越南
    • 其他亚太国家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家
  • 中东和非洲
    • 以色列
    • 埃及
    • 沙乌地阿拉伯
    • 南非
    • UAE
    • 其他中东和非洲国家

第八章 竞争情势

  • 关键成长策略
  • 竞争性标竿分析
  • 竞争对手仪錶板
    • 产业领导者
    • 市场差异化因素
    • 先锋公司
    • 新兴企业
  • 市占率分析

第九章：公司简介

  • EID-Parry（India）Limited/Parry Nutraceuticals
  • Cyanotech Corporation
  • AstaReal Group/Fuji Chemical Industries
  • Algatech Ltd.（Solabia Group）
  • Algalif Iceland ehf.
  • Beijing Gingko Group（BGG）
  • Yunnan Alphy Biotech Co., Ltd.
  • Yunnan Green A Biological Project Co., Ltd.
  • Tianjin Norland Biotech Co., Ltd.
  • Sun Chlorella Corporation
  • BDI BioLife Science GmbH
  • Atacama Bio Natural Products SA
  • Shaivaa Algaetech LLP
  • PIVEG, Inc.
  • Others

第十章附录

简介目录
Product Code: MRFB - 104446

Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets, Whole Biomass Powder, Water Dispersible Powder}; Astaxanthin Bulk Finished Products {Capsules/Softgels, Tablets}); Application (Nutraceuticals, Aquaculture & Animal Feed, Cosmetics, Food & Beverages, Pharmaceuticals), and Geography - Global Forecast to 2036

According to the research report titled, 'Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets, Whole Biomass Powder, Water Dispersible Powder}; Astaxanthin Bulk Finished Products {Capsules/Softgels, Tablets}); Application (Nutraceuticals, Aquaculture & Animal Feed, Cosmetics, Food & Beverages, Pharmaceuticals), and Geography - Global Forecast to 2036,' the global Haematococcus pluvialis market is projected to reach USD 348.8 million by 2036 from USD 116.4 million in 2026, growing at a CAGR of 11.6% during the forecast period (2026-2036). In terms of volume, the market is expected to expand from 682 tons in 2026 to approximately 2,693 tons by 2036, at a CAGR of 13.0%. The growth of this market is primarily driven by the increasing demand for natural astaxanthin in nutraceuticals and dietary supplements, the growing demand for natural food colorants and clean-label ingredients, and the rising adoption of natural astaxanthin in aquaculture and animal nutrition.

Haematococcus pluvialis is a freshwater green microalga recognized as the most prolific natural source of astaxanthin, capable of accumulating this potent ketocarotenoid up to 3-5% of its dry biomass weight. Natural astaxanthin derived from H. pluvialis is documented to be exponentially stronger than traditional antioxidants like vitamin C and vitamin E. A major driver for the market is the global transition from synthetic to natural, clean-label antioxidant ingredients across downstream industries, supported by growing consumer awareness of the health benefits of natural carotenoids. While high production costs and complex cultivation processes remain challenges, advancements in photobioreactor technology and expanding applications in functional foods and beverages are expected to provide significant growth opportunities.

Market Segmentation

The global Haematococcus pluvialis market is segmented by product (astaxanthin ingredients and astaxanthin bulk finished products), application (nutraceuticals, aquaculture & animal feed, cosmetics, food & beverages, and pharmaceuticals), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, the astaxanthin ingredients segment is expected to hold the largest share of the global Haematococcus pluvialis market in 2026. This segment includes oleoresin, beadlets, whole biomass powder, and water-dispersible powder, which are widely used as upstream inputs in nutraceutical, food, cosmetic, and feed formulations. However, the astaxanthin bulk finished products segment-comprising capsules, softgels, and tablets-is projected to register faster growth during the forecast period, driven by the increasing consumer preference for ready-to-consume antioxidant supplements.

Based on Application

By application, the nutraceuticals segment is expected to account for the largest share of the market in 2026. This dominance is attributed to the extensive use of natural astaxanthin as a dietary supplement ingredient for cardiovascular, eye, and skin health. The pharmaceuticals segment is projected to register the highest CAGR during the forecast period, fueled by increasing research into the therapeutic potential of astaxanthin for inflammation management and neuroprotection. The cosmetics and personal care segment is also witnessing significant traction, particularly in anti-aging and skin protection formulations.

Geographic Analysis

In 2026, North America is expected to account for the largest share of the global Haematococcus pluvialis market. The region's leadership is driven by strong consumer demand for natural dietary supplements, a well-established nutraceutical industry, and favorable regulatory acceptance of H. pluvialis-derived astaxanthin. The U.S. remains the primary market, characterized by high consumer awareness of preventive healthcare. The key companies operating in the North America market include Cyanotech Corporation (U.S.) and PIVEG, Inc. (U.S.).

Asia-Pacific is projected to register the fastest CAGR during the forecast period. This growth is fueled by the massive expansion of microalgae cultivation capacity in China and the growing adoption of natural astaxanthin in nutraceutical and functional food applications across India, Japan, and South Korea. Rising investments in advanced photobioreactor systems are supporting regional market growth. The key companies operating in the Asia-Pacific market include E.I.D.-Parry (India) Limited / Parry Nutraceuticals, Beijing Gingko Group (BGG) (China), and Yunnan Alphy Biotech Co., Ltd. (China).

Europe remains a critical market, driven by the increasing demand for natural food colorants and the stringent EU regulations on synthetic additives. The region is a hub for high-purity microalgae production, particularly in Iceland and Germany. The key companies operating in the Europe market include Algalif Iceland ehf. (Iceland) and BDI BioLife Science GmbH (Austria).

Key Players

The key players operating in the global Haematococcus pluvialis market include E.I.D.-Parry (India) Limited / Parry Nutraceuticals (India), Cyanotech Corporation (U.S.), AstaReal Group / Fuji Chemical Industries (Japan), Algatech Ltd. (Solabia Group) (Israel), Algalif Iceland ehf. (Iceland), Beijing Gingko Group (BGG) (China), Yunnan Alphy Biotech Co., Ltd. (China), Yunnan Green A Biological Project Co., Ltd. (China), Tianjin Norland Biotech Co., Ltd. (China), Sun Chlorella Corporation (Japan), BDI BioLife Science GmbH (Austria), Atacama Bio Natural Products S.A. (Chile), Shaivaa Algaetech LLP (India), and PIVEG, Inc. (U.S.).

Key Questions Answered in the Report-

  • What is the value of revenue generated from the global Haematococcus pluvialis market?
  • At what rate is the Haematococcus pluvialis market demand projected to grow for the next 10 years?
  • What are the historical market sizes and growth rates of the Haematococcus pluvialis market?
  • What are the major factors impacting the growth of this market? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of product and application are expected to create major traction for the vendors in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the Haematococcus pluvialis market?
  • Who are the major players in the Haematococcus pluvialis market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the Haematococcus pluvialis market? What are the impacts of these strategic developments on the market?

Scope of the Report:

  • Haematococcus Pluvialis Market Assessment -- by Product

Astaxanthin Ingredients (Astaxanthin Oleoresin, Beadlets, Whole Biomass Powder, Water Dispersible Powder)

Astaxanthin Bulk Finished Products (Capsules/Softgels, Tablets, Liquid Formulations)

  • Haematococcus Pluvialis Market Assessment -- by Application

Nutraceuticals & Dietary Supplements

Aquaculture & Animal Feed

Cosmetics & Personal Care

Food & Beverages

Pharmaceuticals

  • Haematococcus Pluvialis Market Assessment -- by Geography

North America (U.S., Canada)

Europe (Germany, U.K., France, Italy, Spain, Netherlands, Denmark, Sweden, Rest of Europe)

Asia-Pacific (China, Japan, India, South Korea, Australia, Vietnam, Rest of Asia-Pacific)

Latin America (Brazil, Mexico, Argentina, Rest of Latin America)

Middle East & Africa (Israel, Egypt, Saudi Arabia, South Africa, UAE, Rest of Middle East & Africa)

TABLE OF CONTENTS

1. Introduction

  • 1.1 Market Definition
  • 1.2 Market Ecosystem
  • 1.3 Currency and Limitations
    • 1.3.1 Currency
    • 1.3.2 Limitations
  • 1.4 Key Stakeholders

2. Research Methodology

  • 2.1 Research Approach
  • 2.2 Data Collection & Validation Process
    • 2.2.1 Secondary Research
    • 2.2.2 Primary Research & Validation
      • 2.2.2.1 Primary Interviews with Experts
      • 2.2.2.2 Approaches for Country-/Region-Level Analysis
  • 2.3 Market Estimation
    • 2.3.1 Bottom-Up Approach
    • 2.3.2 Top-Down Approach
    • 2.3.3 Growth Forecast
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

3. Executive Summary

  • 3.1 Overview
  • 3.2 Market Analysis, by Product
  • 3.3 Market Analysis, by Application
  • 3.4 Market Analysis, by Geography
  • 3.5 Competitive Analysis

4. Market Insights

  • 4.1 Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Natural Astaxanthin in Nutraceuticals and Dietary Supplements
    • 4.2.2 Growing Demand for Natural Food Colorants and Clean-Label Ingredients
    • 4.2.3 Rising Adoption of Natural Astaxanthin in Aquaculture and Animal Nutrition
    • 4.2.4 Expanding Cosmetic Applications Driven by Anti-Aging and UV-Protection Properties
    • 4.2.5 Growing Research Supporting Astaxanthin's Health Benefits
  • 4.3 Market Restraints
    • 4.3.1 High Production Costs of Natural Astaxanthin
    • 4.3.2 Complex Cultivation and Extraction Processes
  • 4.4 Market Opportunities
    • 4.4.1 Advances in Photobioreactor Cultivation Technologies
    • 4.4.2 Expanding Applications in Functional Foods and Beverages
    • 4.4.3 Growing Demand for Natural Ingredients in Cosmetics and Personal Care
  • 4.5 Market Challenges
    • 4.5.1 Competition from Synthetic Astaxanthin in Aquaculture Applications
    • 4.5.2 Supply Chain Constraints and Production Scalability
  • 4.6 Market Trends
    • 4.6.1 Expansion of Closed Photobioreactor Production Systems
    • 4.6.2 Development of Microencapsulation and Stabilization Technologies
    • 4.6.3 Rising Demand for Natural Astaxanthin in Sports Nutrition
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry
  • 4.8 Value Chain Analysis
    • 4.8.1 Strain Development and Inoculum Preparation
    • 4.8.2 Cultivation (Open Ponds, Closed PBR Systems)
    • 4.8.3 Harvesting and Biomass Processing
    • 4.8.4 Astaxanthin Extraction and Purification
    • 4.8.5 Formulation and Packaging
    • 4.8.6 Distribution and End-Use Applications

5. Haematococcus Pluvialis Market Assessment-by Product

  • 5.1 Overview
  • 5.2 Astaxanthin Ingredients
    • 5.2.1 Astaxanthin Oleoresin
    • 5.2.2 Beadlets
    • 5.2.3 Biomass Powder
    • 5.2.4 Water-Dispersible Powder
  • 5.3 Astaxanthin Finished Formulations
    • 5.3.1 Capsules / Softgels
    • 5.3.2 Tablets
    • 5.3.3 Liquid Formulations

6. Haematococcus Pluvialis Market Assessment-by Application

  • 6.1 Overview
  • 6.2 Nutraceuticals & Dietary Supplements
  • 6.3 Aquaculture & Animal Feed
  • 6.4 Cosmetics & Personal Care
  • 6.5 Food & Beverages
  • 6.6 Pharmaceuticals

7. Haematococcus Pluvialis Market Assessment-by Geography

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Denmark
    • 7.3.8 Sweden
    • 7.3.9 Rest of Europe
  • 7.4 Asia-Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Vietnam
    • 7.4.7 Rest of Asia-Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 Israel
    • 7.6.2 Egypt
    • 7.6.3 Saudi Arabia
    • 7.6.4 South Africa
    • 7.6.5 UAE
    • 7.6.6 Rest of Middle East & Africa

8. Competitive Landscape

  • 8.1 Overview
  • 8.2 Key Growth Strategies
  • 8.3 Competitive Benchmarking
  • 8.4 Competitive Dashboard
    • 8.4.1 Industry Leaders
    • 8.4.2 Market Differentiators
    • 8.4.3 Vanguards
    • 8.4.4 Emerging Companies
  • 8.5 Market Share Analysis

9. Company Profiles

  • 9.1 E.I.D.-Parry (India) Limited / Parry Nutraceuticals
  • 9.2 Cyanotech Corporation
  • 9.3 AstaReal Group / Fuji Chemical Industries
  • 9.4 Algatech Ltd. (Solabia Group)
  • 9.5 Algalif Iceland ehf.
  • 9.6 Beijing Gingko Group (BGG)
  • 9.7 Yunnan Alphy Biotech Co., Ltd.
  • 9.8 Yunnan Green A Biological Project Co., Ltd.
  • 9.9 Tianjin Norland Biotech Co., Ltd.
  • 9.10 Sun Chlorella Corporation
  • 9.11 BDI BioLife Science GmbH
  • 9.12 Atacama Bio Natural Products S.A.
  • 9.13 Shaivaa Algaetech LLP
  • 9.14 PIVEG, Inc.
  • 9.15 Others

10. Appendix

  • 10.1 Available Customization
  • 10.2 Related Reports